Koers Eastgate Biotech Corp. Other OTC
Aandelen
ETBI
US2772531008
Farmaceutische producten
Omzet 2015 | 0,13 0,12 | Omzet 2016 | - | Marktkapitalisatie | 9,82 mln. 9,09 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2015 | -4 mln. -3,7 mln. | Nettowinst (verlies) 2016 | -2 mln. -1,85 mln. | EV/omzet 2015 | 52.069.161 x |
Nettoschuld 2015 | 1,35 mln. 1,25 mln. | Nettoschuld 2016 | 1,72 mln. 1,59 mln. | EV/omzet 2016 | - |
K/w-verhouding 2015 |
-0,85
x | K/w-verhouding 2016 |
-3,28
x | Werknemers | - |
Dividendrendement 2015 * |
-
| Dividendrendement 2016 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Rose Perri
CEO | Chief Executive Officer | 55 | 15-01-15 |
William Abajian
PSD | President | 66 | 01-06-16 |
Ishaan Sundar
CTO | Chief Tech/Sci/R&D Officer | - | 12-04-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Anna Gluskin
BRD | Director/Board Member | 68 | 22-05-12 |
Rose Perri
CEO | Chief Executive Officer | 55 | 15-01-15 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+38,69% | 723 mld. | |
+34,28% | 595 mld. | |
-4,49% | 369 mld. | |
+20,24% | 332 mld. | |
+2,12% | 282 mld. | |
+17,02% | 244 mld. | |
+9,31% | 208 mld. | |
-5,07% | 205 mld. | |
-0,35% | 168 mld. |